You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a Biochemical Diagnosis for Creutzfeldt Jakob disease

    SBC: Amprion, Inc.            Topic: 101

    ABSTRACT Human prion diseases are infectious and invariably fatal neurodegenerative diseases including sporadic Creutzfeldt Jakob disease sCJD the most common form and variant CJD vCJD which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy Currently there is not sensitive objective and non invasive biochemical diagnosis for these diseases and even ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Rapid Identification of Pathogenic Bacteria in Blood causing Sepsis

    SBC: ISENSE, LLC            Topic: NIAID

    Sepsis is the leading cause of deaths in US hospitals contributing to or causing of all US hospital deaths and is the most expensive condition treated in US hospitals costing more than $ billion annually More than million blood culture bottles are produced annually with a market size greater than $ B in the US and EU alone The two year phase II period spanned February to F ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

    SBC: Apex Biomedical Company, LLC            Topic: 106

    Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative strategies must be emphasized in high risk activities to reduce the individual and societal burden of this pervasive injury Bicycle activities account for of all sports related TBI with over annual injuries in the US In an e ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment

    SBC: ARTANN LABORATORIES, INC.            Topic: N

    Pelvic organ prolapse POP is a highly prevalent condition affecting over of women in the US during their lifetimes Urinary incontinence UI affects an estimated of women Both POP and UI are more common in women than in men and their prevalence is increased with age Some loss of utero vaginal support occurs in most adult women however the true etiology of prolapse and differences se ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. A Cytomegalovirus Vectored Chagas Disease Therapeutic Vaccine

    SBC: TOMEGAVAX, INC.            Topic: NIAID

    Abstract The goal of this project is to utilize cytomegalovirus CMV vectors to develop a therapeutic vaccine against Trypanosoma cruzi the causative agent of Chagas disease Although the most common transmission route is by a triatomine bug vector known as the kissing bug Chagas disease is also spread vertically from mother to child and along blood born routes such as organ transplant and tr ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. "A Tool to Improve Evaluation of Patient Navigation Services in Under-served Populations"

    SBC: NATIVE AMERICAN CANCER INITIATIVES, INC.            Topic: NIMHD

    Native American Cancer Initiatives Inc NACI is a woman owned minority American Indian business with fewer than three full time equivalent employees This for profit company founded in has the mission to provide technical assistance and products to communities patients researchers academicians universities research institutions and professionals on Native Americans cultural iss ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Development of an information rich assay for C ORF as a test for ALS and FTD

    SBC: ASURAGEN, INC.            Topic: 104

    Project Summary The long term goal of this project is to develop validate and commercialize an assay for improved analysis of C orf a gene on chromosome that is linked to frontotemporal dementia FTD and amyotrophic lateral sclerosis ALS Expansion of a guanine and cytosine rich hexanucleotide repeat GGGGCC in the non coding region of C orf is associated with of familial ALS Th ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Discovery of alpha4beta2 Nicotinic Receptor Antagonists as Alcohol Abuse Medications

    SBC: ASSUAGE PHARMACEUTICALS, INC.            Topic: NIAAA

    PROJECT SUMMARY Alcohol addiction and disorders associated to excessive alcohol use are a serious public health problem in the United States and in other parts of the world Current pharmacotherapies for the treatment of these disorders show limited efficacy Preclinical and clinical findings point to nicotinic acetylcholine receptors nAChRs as an alternative promising target for the developmen ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia

    SBC: VIROGENOMICS BIODEVELOPMENT INC            Topic: 102

    Project Summary All cancer patients live with the possibility that their cancer will recur and many patients develop secondary cancers as a result of treatments used for their original cancer This project addresses the problem of drug resistance and disease recurrence in cancer by leveraging unique single nanoparticle techniques to identify rare often hidden drug resistant cells in leukemia ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. HIGHLY INNOVATED TARGETED THERAPY OF MELANOMA

    SBC: HOUSTON PHARMECUTICAL INC            Topic: 102

    Despite the recent development of novel therapeutic approaches no curative treatment is available for advanced stage melanoma with year survival below Targeted therapy is one of the most promising therapeutic strategies to the treatment of cancer and is a key component of precision medicine which aims to individualize cancer treatment for a given patient IL RA an oncogenic isoform o ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government